Image of A new medical therapy for anemia in thalassemia

LITERATURE

A new medical therapy for anemia in thalassemia


In this issue of Blood, Piga et al report results of a phase 2, open label, nonrandomized, uncontrolled dose-finding study evaluating the effects of luspatercept on erythroid maturation and differentiation in adult patients with b-thalassemia.1 A high percentage of patients had an increase in hemoglobin or a reduction in transfusion burden, which helped lay the basis for
future randomized trials


Availability

REQJ659-01Titan CenterAvailable

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
Blood 2019;133(12):1267-1269
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous